Skip to main content
. 2018 May 31;51(5):1702375. doi: 10.1183/13993003.02375-2017

TABLE 2.

Biological, microbiological and radiological characteristics at baseline, and treatment and outcome of the 200 patients included in the PneumOLD-CT study

Characteristics# n (%) Median (IQR)
Biological
 White blood cell count 103 per mm3 (on admission) 11.0 (8.2–14.0)
 proBNP ng·L−1 (range <300 ng·L−1) (N=170) 1836 (667–3801)
 CRP mg·L−1 (range 0–10 mg·L−1) 84.0 (45.8–159.6)
 PCT µg·L−1 (range <0.25 µg·L−1) (N=185) 0.33 (0.13–1.30)
 Urea mmol·L−1 7.9 (6.0–11.9)
 Creatinine µmol·L−1 97.0 (77.0–133.0)
 Albumin g·L−1 (N=193) 35.0 (32.0–38.0)
 Prealbumin mg·L−1 (N=193) 122.0 (95.0–162.0)
Microbiological
 Positive culture
  Blood (N=192) 11 (5.7)
  Urinary (N=177) 82 (46.3)
  Sputum (N=81) 36 (44.4)
  Pleural effusion (N=6) 0
 Positive urinary antigen
  Legionella (N=183) 0
  Pneumococcal (N=178) 8 (4.5)
 Positive serology (IgM)
  Legionella pneumophila 2 (1)
  Chlamydophila pneumoniae 4 (2)
  Mycoplasma pneumoniae 3 (1.5)
Radiological
 Chest radiography
  Standing 66 (33)
  Two incidences 63 (31.5)
 Delay of LDCT chest scan h 2.2 (0.9–15.4)
 Radiologist's opinion on quality (good/satisfactory) 127 (63.5)
 Radiologist's estimate of pneumonia probability
  High 103 (51.5)  
  Intermediate 23 (11.5)  
  Low 74 (37.0)  
Treatment
 Duration of AT days 7 (6–9)
Outcome
 Transfer to intermediate care unit or ICU 13 (7.0)
 30-day mortality 11 (5.4)
 90-day mortality 30 (15.0)

IQR: interquartile range; proBNP: pro-brain natriuretic peptide; CRP: C-reactive protein; PCT: procalcitonin; IgM: immunoglobulin M; LDCT: low-dose computed tomography; AT: antimicrobial therapy; ICU: intensive care unit. #: the number of patients (N) is 200 unless otherwise stated.